GALLO, Davide
 Distribuzione geografica
Continente #
NA - Nord America 187
EU - Europa 113
AS - Asia 63
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 367
Nazione #
US - Stati Uniti d'America 186
CN - Cina 30
SE - Svezia 23
AT - Austria 20
SG - Singapore 17
DE - Germania 15
IE - Irlanda 13
UA - Ucraina 13
FI - Finlandia 8
IT - Italia 8
KR - Corea 8
FR - Francia 7
PL - Polonia 4
IN - India 3
EG - Egitto 2
EU - Europa 2
GB - Regno Unito 2
CA - Canada 1
HK - Hong Kong 1
IR - Iran 1
PH - Filippine 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 367
Città #
Chandler 25
Vienna 20
Houston 18
Santa Clara 16
Singapore 16
Dublin 13
Ann Arbor 12
Beijing 8
Dearborn 7
Nyköping 7
Ashburn 6
Fremont 6
Jacksonville 6
Munich 6
Guangzhou 5
Hangzhou 5
Boardman 4
Boston 4
Columbus 4
Princeton 4
Torino 4
Wilmington 4
Iowa City 3
Medford 3
Shanghai 3
Zhengzhou 3
Athens 2
Cairo 2
Poznan 2
San Mateo 2
Villeurbanne 2
Dallas 1
Düsseldorf 1
Falls Church 1
Hefei 1
Los Angeles 1
Nanjing 1
Rouen 1
Sassari 1
Seattle 1
Toronto 1
Washington 1
Woodbridge 1
Totale 234
Nome #
Obestatin promotes glut-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 105
QRFP induces β-cell and human islet cell survival and insulin secretion and promotes glucose uptake in β-cells, adipocytes and muscle cells 94
Obestatin promotes GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 91
Endometriotic cell proliferation and survival are inhibited by somatostatin analogues and GHRH antagonists 85
Totale 375
Categoria #
all - tutte 1.092
article - articoli 0
book - libri 0
conference - conferenze 1.092
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 4 17 4 2 2 4 5 2
2020/202131 6 3 0 1 8 1 3 3 1 2 1 2
2021/202248 1 0 1 5 4 3 4 3 1 3 13 10
2022/202370 6 8 1 11 6 17 4 6 8 1 2 0
2023/202430 5 8 3 1 2 3 1 0 0 2 2 3
2024/202549 0 14 3 8 24 0 0 0 0 0 0 0
Totale 375